CLOUD-CLONE CORP.WUHAN Press Releases - EIN Presswire - Press Release Distribution Service

Published on August 10, 2026 - 04:47 GMT

Cloud-Clone Small Molecule ELISA Kits: Unraveling the Mysteries of Microscopic Messengers

Hapten‑Based Competitive ELISA Technology Empowers Reliable Quantification of Neuroendocrine‑Immune‑Related Small‑Molecule Messengers HUSTON, TX, UNITED STATES, August 10, 2026 /⁨EINPresswire.com⁩/ -- Inside the human body, a sophisticated biological …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on August 10, 2026 - 04:47 GMT

Lab Secondary‑Antibody Selection Guide: Cloud‑Clone Shares Tips for Efficient Reagent Matching

Expert Tips on Secondary‑Antibody Selection: Avoid Common Pitfalls for Reliable Immunoassay Outcomes HUSTON, TX, UNITED STATES, August 10, 2026 /⁨EINPresswire.com⁩/ -- In life science research, the selection of experimental reagents directly determines …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on June 9, 2026 - 11:10 GMT

Global Primary Cell Suppliers Show Differences in Product Species Categories

Global primary cell suppliers differ in species coverage. Cloud-Clone Corp. focus on various animal cells due to regional rules, ethics and material access. HUSTON, TX, UNITED STATES, June 9, 2026 /⁨EINPresswire.com⁩/ -- The global primary cell supply …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on June 2, 2026 - 04:52 GMT

Antibody Selection Strategy: Precisely Match Research Needs, Say Goodbye to Selection Difficulties

Cloud-Clone's antibody guide: match WB, IHC/IF, FCM, ELISA needs with proper Ab traits. 27K+ validated Abs, full tech support. HUSTON, TX, UNITED STATES, June 2, 2026 /⁨EINPresswire.com⁩/ -- Antibody Selection Strategy: Precisely Match Research Needs …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on May 8, 2026 - 07:36 GMT

Cloud-Clone Advances Global Antibody Solutions for Life Science Research and In Vitro Diagnostics

Cloud-Clone has built an integrated antibody R&D and manufacturing platform, focusing on enhancing product consistency and MP for research and diagnostics. HUSTON, TX, UNITED STATES, May 8, 2026 /⁨EINPresswire.com⁩/ -- As the global antibody market …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on April 28, 2026 - 06:19 GMT

Cloud-Clone Introduces Practical Framework to Improve Reliability in Primary Cell Procurement

Cloud-Clone offers over 560 types of primary cells across multiple species, supporting a wide range of research applications. HUSTON, TX, UNITED STATES, April 28, 2026 /⁨EINPresswire.com⁩/ -- Cloud-Clone Introduces Practical Framework to Improve …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on April 17, 2026 - 04:46 GMT

Rising Trend of Myocardial Infarction: Cloud-Clone's Multidimensional Matrix Empowers Cardiovascular Disease Research

Cloud-Clone leverages its expertise in biological reagents, animal models, and primary cells to support global cardiovascular research and medicine development. HUSTON, TX, UNITED STATES, April 17, 2026 /⁨EINPresswire.com⁩/ -- Myocardial infarction (MI …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on April 13, 2026 - 09:28 GMT

‌Four Core Product Matrices of Feline Primary Cells: Cloud-Clone Empowers New Breakthroughs in Animal Research

Cloud-Clone has developed a full-range, high-quality feline primary cell products covering 4 major areas: joint, cardiovascular, stem cell and nervous system. HUSTON, TX, UNITED STATES, April 13, 2026 /⁨EINPresswire.com⁩/ -- In the current era of rapid …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on April 3, 2026 - 04:23 GMT

Cloud-Clone Advances Primary Cell Culture Solutions, Enabling Reliable Research Worldwide

With two decades of dedicated focus in this field, Cloud-Clone has evolved from early-stage exploration into a globally recognized provider of primary cell. HUSTON, TX, UNITED STATES, April 3, 2026 /⁨EINPresswire.com⁩/ -- Primary cells are widely regarded …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on March 27, 2026 - 06:03 GMT

Cloud-Clone Advances Global Obesity Research with Innovative Solutions for Next-Generation Therapeutics

Cloud-Clone drives technological innovation for obesity research, providing validated targets for precise matching of key molecules: GLP-1R, GDF-8 and GDF-15. HUSTON, TX, UNITED STATES, March 27, 2026 /⁨EINPresswire.com⁩/ -- Obesity has emerged as one of …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on March 24, 2026 - 05:49 GMT

Cloud-Clone: Strengthening the Solid Defense Line of Food Safety with Full-Dimensional Detection Products

Cloud-Clone Corp. provides high-quality antibodies, ELISA kits (MAK895Ge21, CEK895Ge, MAV708Ge21, CEV708Ge) to meet the growing demands of food safety HUSTON, TX, UNITED STATES, March 24, 2026 /⁨EINPresswire.com⁩/ -- Cloud-Clone: Strengthening the Solid …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on March 17, 2026 - 05:44 GMT

Cloud-Clone ELISA Kit Supports Landmark Nature Medicine Discovery of Novel IPAH Biomarker

2026 Nature Medicine study: NOTCH3-ECD is a specific IPAH biomarker, Cloud-Clone’s SEL147Hu ELISA Kit powers this breakthrough HUSTON, TX, UNITED STATES, March 17, 2026 /⁨EINPresswire.com⁩/ -- A groundbreaking study published in Nature Medicine in early …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on March 10, 2026 - 05:45 GMT

Cloud-Clone Supports Breakthrough Sepsis Study in Nature Communications by Targeting Truncated Procalcitonin

Cloud-Clone ELISA Kit Provides Accurate Data for German Team, Offering New Strategy for Sepsis Treatment HUSTON, TX, UNITED STATES, March 10, 2026 /⁨EINPresswire.com⁩/ -- In early 2026, a research team from the University of Münster and collaborating …

Distribution channels: Healthcare & Pharmaceuticals Industry, Manufacturing ...

Published on March 3, 2026 - 08:21 GMT

Multiplex Assay Technology Accelerates High-Throughput Cytokine Profiling for Precision Medicine Research

Multiplex assay tech detects multi-biomolecules in single samples on xMAP/CBA, with high sensitivity and consistency for precision medicine research. HUSTON, TX, UNITED STATES, March 3, 2026 /⁨EINPresswire.com⁩/ -- As life science research advances toward …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on February 26, 2026 - 16:00 GMT

Bridging In Vivo Reality and In Vitro Research: Global Market Trends and Competencies of Leading Primary Cell Suppliers

This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, and ScienCell drive drug research. HUSTON, TX, UNITED STATES, February 26, 2026 /⁨EINPresswire.com⁩/ -- Primary cells are cell …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on February 15, 2026 - 00:00 GMT

Primary Cells vs. Cell Lines: Cloud-Clone Corp. Empowers Researchers to Choose the Optimal Path for Discovery

The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of Life Science Research WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /⁨EINPresswire.com⁩/ -- In the complex landscape of life science …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on February 6, 2026 - 11:00 GMT

Breaking the Efficiency Barrier in Life Sciences: How Cloud-Clone Redefines Research with a Tiny Bead

As an original manufacturer, Cloud-Clone redefines lab efficiency with high-sensitivity multiplex kits, offering a cost-effective alternative for global labs WUHAN, HUBEI PROVINCE, CHINA, February 6, 2026 /⁨EINPresswire.com⁩/ -- Cloud-Clone Corp. Breaks …

Distribution channels: Healthcare & Pharmaceuticals Industry, Natural Disasters ...